최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기韓方眼耳鼻咽喉皮膚科學會誌 = The journal of Korean Medicine Ophthalmology & Otolaryngology & Dermatology, v.31 no.4, 2018년, pp.22 - 30
정창운 (청연의학연구소) , 전선우 (청연의학연구소) , 조희근 (청연의학연구소)
Objectives : The aim of this study is to investigate the relationship between chronic low grade inflammation theory, psoriasis, and herbal medicine. Methods : We reviewed recent studies on the relationship between chronic low-grade inflammation, psoriasis, and herbal medicine through Pubmed. Results...
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
건선의 유병률은? | 건선은 성별과 관계없이 전세계 인구의 약 1∼3% 의 유병률을 보이며 호전과 악화를 반복하는 만성 염증성 피부질환이다 1) . 건선의 발생원인은 아직 명확히 알려져 있지 않지만 발생 기전 상 활성화된 T세포가 중요한 역할을 하는 것으로 알려져 있고, 최근에는 건선환자에서 비만, 대사증후군 등 만성 염증질환의 유병률이 증가되어 있다는 사실들이 지속적으로 보고되고 있는 등 건선이 단순히 피부나 관절뿐 아니라 전신 적인 염증반응을 보이는 질환으로 받아들여지고 있다2-4) . | |
건선이란? | 건선은 성별과 관계없이 전세계 인구의 약 1∼3% 의 유병률을 보이며 호전과 악화를 반복하는 만성 염증성 피부질환이다 1) . 건선의 발생원인은 아직 명확히 알려져 있지 않지만 발생 기전 상 활성화된 T세포가 중요한 역할을 하는 것으로 알려져 있고, 최근에는 건선환자에서 비만, 대사증후군 등 만성 염증질환의 유병률이 증가되어 있다는 사실들이 지속적으로 보고되고 있는 등 건선이 단순히 피부나 관절뿐 아니라 전신 적인 염증반응을 보이는 질환으로 받아들여지고 있다2-4) . | |
만성 염증이 인체에 미치는 영향에 대한 연구결과는 어떠한가? | 건선에서와 같은 전신적인 만성 염증이 인체에 미치는 영향에 대한 연구가 최근 다양한 의과학 분야에서 활발히 진행되고 있다. 특히 NCD(Non-communal Disease)의 증가를 이해하기 위한 여러 노력들을 통해 비만과 스트레스, 염증간의 상호 관계가 밝혀지고 있고, 다양한 내과적 질환뿐만 아니라 피부과질환에 있어 이와 같은 기전이 미치는 영향에 대해서도 점차 폭넓게 규명되는 추세이다 8-10) . |
Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005;141(12):1537-41.
Kremers HM, McEvoy MT, Dann FJ, Gabriel SE. Heart disease in psoriasis. J Am Acad Dermatol. 2007;57(2):347-54.
Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55(5):829-35.
Heymann WR. Psoriasis: the heart of the matter. J Am Acad Dermatol. 2008;58(3):477-8.
Griffiths CE, Katsambas A, Dijkmans BA, Finlay AY, Ho VC, Johnston A, et al. Update on the use of ciclosporin in immune-mediated dermatoses. Br J Dermatol. 2006;155 Suppl 2:1-16.
Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005;53(4):573.
Strober B, Teller C, Yamauchi P, Miller JL, Hooper M, Yang YC, et al. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis. Br J Dermatol. 2008;159(2):322-30.
Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340(2):115-26.
Fernandez-Sanchez A, Madrigal-Santillan E, Bautista M, et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci. 2011; 12(5):3117-32.
Berk M, Williams LJ, Jacka FN, et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 2013;11:200.
McArdle MA, Finucane OM, Connaughton RM, et al. Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne). 2013;4:52.
Heymsfield SB, Wadden TA. Mechanisms, Pathophysiology, and Management of Obesity. N Engl J Med. 2017;376(15):1492.
Liu C, Huang Y. Chinese Herbal Medicine on Cardiovascular Diseases and the Mechanisms of Action. Front Pharmacol. 2016;7:469.
Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006;298(7):321-8.
Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol. 1995;32(6):982-6.
Christophers E. Comorbidities in psoriasis. Clin Dermatol. 2007;25(6):529-34.
Medzhitov R, Origin and physiological roles of inflammation. Nature. 2008; 454(7203):428-35.
Rainer H. Straub, Carsten Schradin. Chronic inflammatory systemic diseases: An evolutionary trade-off betweenacutely beneficial but chronically harmful programs, Evol Med Public Health. 2016;2016(1):37-51.
Netea MG, Balkwill F, Chonchol M, et al. A guiding map for inflammation. Nat Immunol. 2017;18(8):826-31.
Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41:401-7.
Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496-509.
Parisi R, Symmons DP, Griffiths CE, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377-85.
Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(2):205-12.
Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69:4-9.
Rousset L, Halioua B. Stress and psoriasis. Int J Dermatol. 2018;57(10):1165-172.
Zachariae R, Zachariae H, Blomqvist K, et al. Self-reportedstress reactivity and psoriasis-related stress of nordic psoriasissufferers. J Eur Acad Dermatol Venereol. 2004;18(1):27-36.
Song H, Fang F, Tomasson G, et al. Association of Stress-Related Disorders With Subsequent Autoimmune Disease. JAMA. 2018;319(23):2388-400.
Correia B, Torres T. Obesity: a key component of psoriasis. Acta Biomed. 2015;86(2):121-9.
Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: a systematic review and metaanalysis of observational studies. Nutr Diabetes. 2012;2:e54.
Dogra S, Mahajan R. Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring. Indian Dermatol Online J. 2016;7(6):471-80.
Mason JC, Libby P. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J. 2015;36(8):482-9c.
Reich K, The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol. 2012;26:3-11.
Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001; 103(13):1813-8.
Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol. 2004; 29(8):439-93.
Mora S, Lee IM, Buring JE, Ridker PM. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA. 2006;295(12):1412-9.
Strober B, Teller C, Yamauchi P, Miller JL, Hooper M, Yang YC, et al. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis. Br J Dermatol. 2008;159(2):322-30.
Sterry W, Strober BE, Menter A. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol. 2007;157(4):649-55.
Vandevoorde V, Haegeman G, Fiers W. TNF-mediated IL6 gene expression and cytotoxicity are co-inducible in TNFresistant L929 cells. FEBS Lett. 1992;302(3):235-8.
Naldi L, Peli L, Parazzini F. Association of Early-Stage Psoriasis With Smoking and Male Alcohol Consumption: evidence From an Italian Case-Control Study. Arch Dermatol. 1999;135(12):1479-84.
Davidovici BB, Sattar N, Prinz J, et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol. 2010;130(7):1785-96.
Ryan C, Kirby B. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. Dermatol Clin. 2015;33(1):41-55.
Greb JE, Goldminz AM, Elder JT, et al. Psoriasis. Nat Rev Dis Primers. 2016;2:16082.
Meng S, Lin Z, Wang Y, Wang Z, Li P, Zheng Y. Psoriasis therapy by Chinese medicine and modern agents. Chin Med. 2018;13:16.
Guan F, Lam W, Hu R, et al. Majority of Chinese Medicine Herb Category "Qing Re Yao" Have Multiple Mechanisms of Antiinflammatory Activity. Sci Rep. 2018;8(1):7416.
Cheng H-M, Wu Y-C, Wang Q, et al. Clinical efficacy and IL-17 targeting mechanism of Indigo naturalis as a topical agent in moderate psoriasis. BMC Complement Altern Med. 2017;17(1):439.
De Sa DC, Festa Neto C. Inflammasomes and dermatology. An Bras Dermatol. 2016;91(5):566-78.
Tozser J, Benko S. Natural Compounds as Regulators of NLRP3 Inflammasome-Mediated IL- $1{\beta}$ Production. Mediators Inflamm. 2016;2016:5460302.
Lin X, Huang T, Oxidative stress in psoriasis and potential therapeutic use of antioxidants. Free Radic Res. 2016;50(6):585-95.
Hirayama A, Oowada S, Ito H, et al. Clinical significance of redox effects of Kampo formulae, a traditional Japanese herbal medicine: comprehensive estimation of multiple antioxidative activities. J Clin Biochem Nutr. 2018;62(1):39-48.
Wang D, Gu J, Zhu W, et al. PDTCM: a systems pharmacology platform of traditional Chinese medicine for psoriasis. Ann Med. 2017;49(8):652-60.
Wu M, Deng Y, Li S, et al. The Immunoregulatory Effects of Traditional Chinese Medicine on Psoriasis via its Action on Interleukin: Advances and Considerations. Am J Chin Med. 2018;46(4):739-50.
Yan Y, Liu W, Andres P, et al. Exploratory clinical trial to evaluate the efficacy of a topical traditional chinese herbal medicine in psoriasis vulgaris. Evid Based Complement Alternat Med. 2015;2015:719641.
Lin YK, See LC, Huang YH, Comparison of indirubin concentrations in indigo naturalis ointment for psoriasis treatment: a randomized, double-blind, dosage-controlled trial. Br J Dermatol. 2018;178(1):124-31.
Sun W, Gao Y, Yu X, et al. 'Psoriasis 1' reduces psoriasis-like skin inflammation by inhibiting the VDR-mediated nuclear NF- ${\kappa}B$ and STAT signaling pathways. Mol Med Rep. 2018;18(3):2733-43.
Lu C, Liu H, Jin X. Herbal Components of a Novel Formula PSORI-CM02 Interdependently Suppress Allograft Rejection and Induce CD8+CD122+PD-1+ Regulatory T Cells. Front Pharmacol. 2018;9:88.
Liu Q, Yin W, Han L, et al. Diarylheptanoid from rhizomes of Curcuma kwangsiensis (DCK) inhibited imiquimod-induced dendritic cells activation and Th1/Th17 differentiation. Int Immunopharmacol. 2018;56:339-48.
Geng X, Shi H, Ye F, et al. Matrine inhibits itching by lowering the activity of calcium channel. Sci Rep. 2018;8(1):11328.
Parker S, Zhang CS, Yu JJ, et al. Oral Chinese herbal medicine versus placebo for psoriasis vulgaris: A systematic review. J Dermatolog Treat. 2017;28(1):21-31.
Zhang CS, Yang L, Zhang AL, et al. Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin. J Altern Complement Med. 2016;22(3):174-88.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.